Wegovy, eat your heart out.
A team of researchers at Stanford Medicine conducted the study,publishedlast week in the journal Nature.
The emergence of semaglutide and similar drugs in recent years has beentruly revolutionaryfor the field of obesity medicine.
The GLP-1 medications Wegovy, Victoza, and Ozempic.© Michael Siluk/UCG/Universal Images Group via Getty
Does Ozempic Really Cause Thyroid Cancer?
In that vein, the Stanford Medicine researchers devised a novel strategy to find their drug candidate.
Many hormones in the body are activated only when their precursors are cleaved by specific enzymes.
These precursors are called prohormones, and the family of enzymes that chop them up are called prohormone convertases.
They decided to see if they could find other useful hunger-related hormones naturally produced by the enzyme.
said study senior researcher Katrin Svensson, an assistant professor of pathology at Stanford, in astatementfrom the university.
In contrast, BRP appears to act specifically in the hypothalamus, which controls appetite and metabolism.
The teams findings are, of course, preliminary at this point.
News from the future, delivered to your present.
You May Also Like
Trump Is Promising to Lower Drug Prices.
Millions Share a Deadly Genetic Heart Risk.
